| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)
|
Palmerini, Emanuela
|
|
|
183 |
C |
p. 11-23
|
artikel
|
| 2 |
Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018
|
Bylicki, Olivier
|
|
|
183 |
C |
p. 38-48
|
artikel
|
| 3 |
Cancers attributable to infectious agents in Italy
|
Collatuzzo, Giulia
|
|
|
183 |
C |
p. 69-78
|
artikel
|
| 4 |
Characterisation and outcome of RAC1 mutated melanoma
|
Lodde, Georg C.
|
|
|
183 |
C |
p. 1-10
|
artikel
|
| 5 |
Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma
|
Porth, Isabel
|
|
|
183 |
C |
p. 119-130
|
artikel
|
| 6 |
Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors
|
Tohidinezhad, Fariba
|
|
|
183 |
C |
p. 142-151
|
artikel
|
| 7 |
Durability of response to immune checkpoint inhibitors in metastatic Merkel cell carcinoma after treatment cessation
|
Weppler, Alison M.
|
|
|
183 |
C |
p. 109-118
|
artikel
|
| 8 |
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial
|
TAO, Yungan
|
|
|
183 |
C |
p. 24-37
|
artikel
|
| 9 |
Far-reaching impact of the Russian invasion of Ukraine on global cancer research
|
Bondarenko, Igor
|
|
|
183 |
C |
p. 95-97
|
artikel
|
| 10 |
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes
|
Reck, Martin
|
|
|
183 |
C |
p. 174-187
|
artikel
|
| 11 |
Incidence, mortality and trends of cutaneous squamous cell carcinoma in Germany, the Netherlands, and Scotland
|
Keim, Ulrike
|
|
|
183 |
C |
p. 60-68
|
artikel
|
| 12 |
Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial
|
Hilmi, Marc
|
|
|
183 |
C |
p. 152-161
|
artikel
|
| 13 |
Letter Re: Survival trends in solid cancers in the Nordic countries through 50 years
|
Larønningen, Siri
|
|
|
183 |
C |
p. 188-189
|
artikel
|
| 14 |
Letter re: Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France
|
Guennebaud, Bernard
|
|
|
183 |
C |
p. 171-173
|
artikel
|
| 15 |
Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience
|
Repetto, Matteo
|
|
|
183 |
C |
p. 79-89
|
artikel
|
| 16 |
Multimodal integration of image, epigenetic and clinical data to predict BRAF mutation status in melanoma
|
Schneider, Lucas
|
|
|
183 |
C |
p. 131-138
|
artikel
|
| 17 |
Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the GEOMETRY mono-1 study
|
Wolf, Jürgen
|
|
|
183 |
C |
p. 98-108
|
artikel
|
| 18 |
Refusal of vaccination against influenza and COVID-19 in patients with solid cancers: from bio-ethical issues to solutions
|
Stoeklé, Henri-Corto
|
|
|
183 |
C |
p. 139-141
|
artikel
|
| 19 |
Response to letter entitled: Re: Survival trends in solid cancers in the Nordic countries through 50 years
|
Hemminki, Kari
|
|
|
183 |
C |
p. 190
|
artikel
|
| 20 |
The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trial
|
Bolhuis, Karen
|
|
|
183 |
C |
p. 49-59
|
artikel
|
| 21 |
The safety risk of information overload and bureaucracy in oncology clinical trial conduct
|
van Ravensteijn, Stefan G.
|
|
|
183 |
C |
p. 90-94
|
artikel
|
| 22 |
Uptake of COVID-19 vaccination in people with blood cancer: Population-level cohort study of 12 million patients in England
|
Hirst, Jennifer
|
|
|
183 |
C |
p. 162-170
|
artikel
|
Tijdschrift beschrijving